达格列净对射血分数降低的心力衰竭患者心功能及血清NT-proBNP、cTnⅠ水平的影响OA
Impact of Dapagliflozin on Cardiac Function and Serum NT-proBNP and cTnⅠ Levels of Patients with Heart Failure with Reduced Ejection Fraction
目的 探讨达格列净对射血分数降低的心力衰竭(HFrEF)患者心功能以及血清NT-proBNP、cTnⅠ水平的影响.方法 120 例HFrEF患者随机分为两组.对照组采用标准心力衰竭药物治疗方案进行治疗,观察组在对照组基础上采用达格列净治疗.比较两组的心功能、不良事件以及血清NT-proBNP、cTnⅠ水平.结果 治疗后,观察组的LVEF高于对照组,LVESD、LVEDD以及血清NT-proBNP、cTnⅠ水平均低于对照组(P<0.05).观…查看全部>>
Objective To explore the impact of dapagliflozin on cardiac function and serum NT-proBNP and cTnⅠ levels of patients with heart failure with reduced ejection fraction(HFrEF).Methods A total of 120 patients with HFrEF were randomly divided into two groups.The control group was treated with standard heart failure drug treatment regimen,and the observation group was treated with dapagliflozin on the basis of the control group.The cardiac function,adverse events…查看全部>>
龚庆平;游倩;王鸿权
信阳市人民医院药学部,河南信阳 464000信阳市人民医院药学部,河南信阳 464000信阳市人民医院心内科,河南信阳 464000
临床医学
心力衰竭射血分数降低达格列净心功能不良事件NT-proBNPcTnⅠ
Heart failureReduced ejection fractionDapagliflozinCardiac functionAdverse eventNT-proBNPcTnⅠ
《临床医学工程》 2024 (2)
197-198,2
评论